Volume 59, Issue 6, Pages (June 2001)

Slides:



Advertisements
Similar presentations
Reduced renal function in patients with simple renal cysts
Advertisements

Chemokine response to febrile urinary tract infection
Volume 61, Issue 4, Pages (April 2002)
Volume 54, Issue 2, Pages (August 1998)
Volume 54, Issue 6, Pages (January 1998)
Acute interstitial nephritis
Metabolomic study of cisplatin-induced nephrotoxicity
Kenrick Berend, Gijsbert Van Der Voet, Walther H. Boer 
Volume 66, Issue 5, Pages (November 2004)
Volume 55, Issue 6, Pages (June 1999)
Propofol-related green urine
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 67, Issue 3, Pages (March 2005)
Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent ‘pre-renal’ acute kidney injury?: con  Dileep N. Lobo, Sherif.
Stem cells for kidney repair: useful tool for acute renal failure?
Volume 62, Issue 1, Pages (July 2002)
Acute interstitial nephritis
Reassessment of the care of the patient with chronic kidney disease
C.-W. Tsai, V.-C. Wu, W.-C. Lin, J.-W. Huang, M.-S. Wu
Volume 130, Issue 6, Pages (May 2006)
Volume 66, Issue 4, Pages (October 2004)
Volume 59, Issue 1, Pages (January 2001)
Volume 71, Issue 10, Pages (May 2007)
Volume 57, Issue 3, Pages (March 2000)
Peritubular capillaritis in the renal allograft takes center stage
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
M. Svensson, H. Irjala, C. Svanborg, G. Godaly  Kidney International 
Volume 64, Issue 5, Pages (November 2003)
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load 
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 64, Issue 1, Pages (July 2003)
Volume 70, Issue 11, Pages (December 2006)
Volume 54, Issue 5, Pages (November 1998)
Chemokine response to febrile urinary tract infection
Volume 60, Issue 1, Pages (July 2001)
Volume 56, Issue 1, Pages (July 1999)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Mohamad Zaidan, Julien Adam, Pascale Cervera-Pierot, Dominique Joly 
Volume 61, Issue 1, Pages S106-S109 (January 2002)
Volume 66, Issue 5, Pages (November 2004)
Volume 56, Issue 3, Pages (September 1999)
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Volume 75, Issue 1, Pages (January 2009)
Volume 59, Issue 4, Pages (April 2001)
Volume 67, Issue 1, Pages (January 2005)
Volume 61, Issue 4, Pages (April 2002)
Volume 76, Issue 6, Pages (September 2009)
Volume 70, Issue 6, Pages (September 2006)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
J.M. van den Akker, J.F.M. Wetzels, A.J. Hoitsma  Kidney International 
Volume 65, Issue 4, Pages (April 2004)
Reduced renal function in patients with simple renal cysts
Nephrology Crossword: Glomerulonephritis
The initiation and progression of sickle cell nephropathy
Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease  Shen Xiao, Laszlo Wagner, Rebecca J. Schmidt,
Steven J. Harper, Charles R.V. Tomson, David O. Bates 
Endothelin antagonists in renal disease
Volume 73, Issue 5, Pages (March 2008)
Volume 55, Issue 6, Pages (June 1999)
Volume 63, Issue 2, Pages (February 2003)
Volume 80, Issue 10, Pages (November 2011)
Treatment of the primary hyperoxalurias: A new chapter
Is complement a target for therapy in renal disease?
The Authors Reply: Kidney International
Volume 62, Issue 5, Pages (November 2002)
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
Volume 57, Issue 6, Pages (June 2000)
Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund 
Presentation transcript:

Volume 59, Issue 6, Pages 2054-2061 (June 2001) Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia  Sandrine Florquin, José G. Van Den Berg, Dariusz P. Olszyna, Nike Claessen, Steven M. Opal, Jan J. Weening, Tom Van Der Poll  Kidney International  Volume 59, Issue 6, Pages 2054-2061 (June 2001) DOI: 10.1046/j.1523-1755.2001.00719.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Plasma (A) and urine (B) levels of urokinase plasminogen activator receptor (uPAR) in healthy subjects (□) and in patients with urosepsis (▪). Samples from patients with urosepsis were collected on admission (t = 0) and at two, four, and eight hours after initiation of antibiotic therapy. Results are expressed as mean ± SEM. Patients with urosepsis (N = 30) had higher plasma and urine levels than controls (N = 20) throughout the follow-up (both P < 0.001 at all time points). Kidney International 2001 59, 2054-2061DOI: (10.1046/j.1523-1755.2001.00719.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Plasma and urine concentrations of uPAR during experimental endotoxemia. Plasma (A) and urine (B) concentrations of uPAR are expressed as mean ± SEM. Plasma concentrations of uPAR were measured prior to endotoxin injection (t = 0) and during a follow up of 12 hours in seven healthy volunteers. Urine concentrations were measured prior to endotoxin injection (t < 0) and in urine collected between zero and three hours after endotoxin administration (t = 0 to 3) and between three and six hours after endotoxin administration (t = 3 to 6). The asterisks indicate significant difference from the levels at t = 0 (P < 0.005). Kidney International 2001 59, 2054-2061DOI: (10.1046/j.1523-1755.2001.00719.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Immunostaining for uPAR on renal tissue. Renal tissue obtained from patients with chronic pyelonephritis (A) and from normal part of kidneys removed by nephrectomy for renal cell carcinoma (B) were stained for uPAR. Damaged tubuli were clearly positive for uPAR in chronic pyelonephritis (A), while normal renal tissue did not show any positive staining (B; original magnification ×70). Kidney International 2001 59, 2054-2061DOI: (10.1046/j.1523-1755.2001.00719.x) Copyright © 2001 International Society of Nephrology Terms and Conditions